Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Paxillin anticorps (pTyr118)

PXN Reactivité: Humain WB, ELISA, IHC Hôte: Lapin Polyclonal unconjugated
N° du produit ABIN7138918
  • Antigène Voir toutes Paxillin (PXN) Anticorps
    Paxillin (PXN)
    Épitope
    • 32
    • 25
    • 17
    • 16
    • 11
    • 9
    • 8
    • 7
    • 7
    • 7
    • 7
    • 5
    • 4
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    pTyr118
    Reactivité
    • 205
    • 111
    • 79
    • 23
    • 11
    • 9
    • 8
    • 5
    • 3
    • 3
    • 1
    • 1
    • 1
    • 1
    • 1
    Humain
    Hôte
    • 190
    • 34
    • 1
    Lapin
    Clonalité
    • 175
    • 50
    Polyclonal
    Conjugué
    • 128
    • 10
    • 8
    • 8
    • 8
    • 8
    • 8
    • 8
    • 6
    • 6
    • 4
    • 4
    • 4
    • 4
    • 4
    • 2
    • 2
    • 2
    • 1
    Cet anticorp Paxillin est non-conjugé
    Application
    • 173
    • 66
    • 41
    • 40
    • 40
    • 33
    • 27
    • 25
    • 25
    • 14
    • 14
    • 6
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    Western Blotting (WB), ELISA, Immunohistochemistry (IHC)
     Réactivité croisée
    Humain, Souris, Rat
    Purification
    Antibodies were produced by immunizing rabbits with synthetic phosphopeptide and KLH conjugates. Antibodies were purified by affinity-chromatography using epitope-specific phosphopeptide. Non-phospho specific antibodies were removed by chromatogramphy usi
    Immunogène
    Peptide sequence around phosphorylation site of tyrosine 118 (H-V-Y(p)-S-F) derived from Human Paxillin.
    Isotype
    IgG
    Top Product
    Discover our top product PXN Anticorps primaire
  • Indications d'application
    WB:1:500-1:1000, IHC:1:50-1:100,
    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    Supplied at 1.0 mg/mL in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    -20 °C,-80 °C
    Stockage commentaire
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Antigène
    Paxillin (PXN)
    Autre désignation
    PXN (PXN Produits)
    Synonymes
    anticorps AW108311, anticorps AW123232, anticorps Pax, anticorps CG18061, anticorps CG18576, anticorps CG31794, anticorps CT40481, anticorps CT42454, anticorps DPaxillin, anticorps DPxn, anticorps DPxn37, anticorps Dmel\\CG31794, anticorps Dpax, anticorps DpaxA, anticorps PDLP, anticorps dPax, anticorps pax, anticorps wu:fw71f12, anticorps PXN, anticorps LOC100220858, anticorps paxillin, anticorps Paxillin, anticorps paxillin S homeolog, anticorps paxillin a, anticorps PXN, anticorps Pxn, anticorps Pax, anticorps pxn.S, anticorps pxna, anticorps LOC696336, anticorps pxn
    Sujet

    Background: Cytoskeletal protein involved in actin-membrane attachment at sites of cell adhesion to the extracellular matrix (focal adhesion).

    Tao WA, et al.(2005)Nat Methods.2(8): 591-598.
    Zhang Y, et al.(2005) Mol Cell Proteomics.4(9): 1240-1250.
    Sanders MA, et al.(2005)J Biol Chem.280(25): 23516-23522.
    Rush J, et al.(2004) Nat Biotechnol. 23(1): 94-101.

    Aliases: FLJ16691 antibody, FLJ23042 antibody, Paired box protein Pax 1 antibody, PAX 1 antibody, PAX1 antibody, PAXI_HUMAN antibody, Paxillin alpha antibody, Paxillin antibody, PXN antibody, PXN protein antibody

    UniProt
    P49023
    Pathways
    Signalisation MAPK, EGFR Signaling Pathway, Response to Growth Hormone Stimulus, Cell-Cell Junction Organization, Maintenance of Protein Location, CXCR4-mediated Signaling Events, Signaling Events mediated by VEGFR1 and VEGFR2, Signaling of Hepatocyte Growth Factor Receptor, VEGF Signaling
Vous êtes ici: